Abstract
Induced pluripotent stem cell-derived cardiomyocytes (IPS-CM) are considered by many to be the cornerstone of future approaches to repair the diseased heart. However, current methods for producing IPS-CM typically yield highly variable populations with low batch-to-batch reproducibility. The underlying reasons for this are not fully understood. Here we report on a systematized approach to investigate the effect of maturation in embryoid bodies (EB) vs. “on plate” culture on spontaneous activity and regional Ca2+ synchronization in IPS-CM clusters. A detailed analysis of the temporal and spatial organization of Ca2+ spikes in IPS-CM clusters revealed that the disaggregation of EBs between 0.5 and 2 weeks produced IPS-CM characterized by spontaneous beating and high levels of regional Ca2+ synchronization. These phenomena were typically absent in IPS-CM obtained from older EBs (>2 weeks). The maintenance of all spontaneously active IPS-CM clusters under “on plate” culture conditions promoted the progressive reduction in regional Ca2+ synchronization and the loss of spontaneous Ca2+ spiking. Raising the extracellular [Ca2+] surrounding these quiescent IPS-CM clusters from ~0.4 to 1.8 mM unmasked discrete behaviors typified by either (a) long-lasting Ca2+ elevation that returned to baseline or (b) persistent, large-amplitude Ca2+ oscillations around an increased cytoplasmic [Ca2+]. The different responses of IPS-CM to elevated extracellular [Ca2+] could be traced back to their routes of derivation. The data point to the possibility of predictably influencing IPS-CM phenotype and response to external activation via defined interventions at early stages in their maturation.
Keywords: induced pluripotent stem cells, cardiomyocytes, calcium signaling, synchronization, oscillation, variability
Introduction
The ability to reprogramme adult human somatic cells into an embryonic-like pluripotent state (Takahashi et al., 2007; Yu et al., 2007; Park et al., 2008) has revolutionized stem cell biology and represents a technological keystone in new approaches for cell replacement therapy and repair. In the setting of cardiac disease, the development of protocols for differentiating induced pluripotent stem cells (IPS) into cardiomyocytes (IPS-CM; Zhang et al., 2009; Zwi et al., 2009) has created the platform for new drug screening approaches (Yokoo et al., 2009; Braam et al., 2010; Dick et al., 2010; Matsa et al., 2011; Silvester and George, 2011; Harris et al., 2013; Liang et al., 2013; Mercola et al., 2013; Sinnecker et al., 2013), frameworks for exploring inherited arrhythmogenic cardiac disorders (Carvajal-Vergara et al., 2010; Moretti et al., 2010; Dambrot et al., 2011; Itzhaki et al., 2011a; Yazawa et al., 2011; Itzhaki et al., 2012; Jung et al., 2012; Siu et al., 2012; Caspi et al., 2013; Lan et al., 2013; Matsa et al., 2014) and early investigations into cardiac repair (Oh et al., 2012; Lalit et al., 2014; Masumoto et al., 2014; Savla et al., 2014).
Although there is vast potential for the use of IPS-CM across a variety of patient-relevant arenas, there are some important obstacles to be overcome. One of the main limitations at present is the high levels of variability in IPS-CM phenotype resulting from the various differentiation processes. Despite methodological advances (Burridge et al., 2011; Mummery et al., 2012), the reproducible production of phenotypically consistent IPS-CM in the massive quantities that are required for “regenerative” approaches remains a huge challenge (Dolnikov et al., 2006; Itzhaki et al., 2011b; Silvester and George, 2011; Li et al., 2013).
The maturation of individual cells in multicellular populations is dependent on complex modes of cell-to-cell interactions via electrical, physical and chemical coupling (Nakamura et al., 2009; Kholodenko et al., 2010; George et al., 2012; Boileau et al., 2015). A critical determinant of cell phenotype and fate is the synchronization of intra- and inter-cellular Ca2+ signaling (Nakamura et al., 2009; Kholodenko et al., 2010; Lakatta et al., 2010; George et al., 2012; Thurley et al., 2014; Boileau et al., 2015). Lewis and colleagues recently showed that the functional maturation of embryonic stem cell-derived CMs (eSC-CM) was associated with the enhanced temporal ordering and diminished variability of Ca2+ signaling events within and between eSC-CM (Lewis et al., 2015). Deranged Ca2+ signaling was a hallmark of eSC-CM phenotypic deterioration and drug-induced cytotoxicity (Lewis et al., 2015).
In this study, we report on a systematic approach to reconcile the method of IPS-CM maturation [in embryoid bodies (EB) vs. “on plate” culture] with the extent of regional Ca2+ synchronization in IPS-CM clusters over a 4 week post-differentiation period. The data provide proof-of-concept evidence that IPS-CM phenotype and response to external cues can be directed by controlling very early events in the maturation and culture processes.
Materials and methods
Maintenance of iPS and differentiation into embryoid bodies (EB)
iPS derived from the reprogramming of skin fibroblasts obtained from a 56 year-old male were supplied by Chandran and colleagues (Bilican et al., 2012). iPS were maintained in mTESR1 medium (Stem Cell Technologies), on 25 cm2 culture surfaces that had been pre-coated with GelTrex (1:400 (v/v) in incomplete Dulbecco's Modified Eagle Medium (Life Technologies) for 45 min at 37°C). iPS were grown on a 3-day cycle and adherent cells were detached in small clumps to preserve the structural integrity of iPS populations (Mitalipova et al., 2005) using ReLeSR (Stem Cell Technologies) and subsequently re-seeded at a ratio of 1:3.
iPS were differentiated into IPS-CM via the formation of EBs using an 8-day protocol adapted from Burridge et al. (2011) that uses three different media formulations with RPMI1640 (supplemented with penicillin / streptomycin [1% (v/v), Life Technologies] as the base media (see Figure 1A). On Day 0 of the differentiation process, iPS maintained as above were detached as single cells using cell dissociation buffer (Life Technologies), counted and transferred into media containing PVA (4 mg/ml), 1-thioglycerol (400 μM, Sigma), insulin-transferrin-selenium supplement (ITS, 1% v/v), chemically-defined lipids (1% v/v, Life Technologies), BMP4 (20 ng/ml, R&D), FGF2 (6 ng/ml, Preprotech), and the rho kinase inhibitor Y27632 (1 μM, Abcam Biochemicals). The cell suspension was plated at a density of 10,000 cells/well in V-bottom 96-well plates to promote forced aggregation (Thermo Scientific, 277143). On Day 2 media was replaced with that containing FBS (20% v/v), 1-thioglycerol (400 μM) and Wnt signaling inhibitors KY02111 (Minami et al., 2012) and XAV939 (Wang et al., 2011; both 10 μM, Tocris). On day 4, iPS were incubated with ITS (1% v/v), lipid (1% v/v), 1-thioglycerol (400 μM), KY02111 (10 μM), and XAV939 (10 μM). EBs were typically obtained on day 4 and were left for 1 day prior to their transfer (to day 5) This protocol avoids the rapid collapse of EB structure reported by others (Burridge et al., 2011). Briefly, on day 5 EBs were separated from the bottom of the well by gentle pipetting and were transferred with all of the supporting media to U-bottomed plates. EBs were subsequently maintained in RPMI1640 containing ITS (1% v/v), 1-thioglycerol (400 μM) and lipids (1% v/v). All plates were maintained at 37°C and 5% CO2.
Analysis of EB structure using confocal laser scanning microscopy (CLSM)
EBs were fixed using 4% (v/v) formaldehyde in phosphate buffered saline [PBS, containing (in mM): NaCl (140), KCl (2.7), Na2HPO4 (10), NaH2PO4 (2), pH7.4)] for 5–10 min at room temperature, rehydrated in PBS (30 min) and component cells were stained using propidium iodide (PI, 10–25 μM) in PBS which was allowed to equilibrate through fixed EBs. PI labels all post-fixation cellular material (Martin et al., 2005) with spread of the dye through the EB structure facilitated by gap junctions between coupled IPS-CM (George et al., 1998). PI does not accumulate in acellular areas of EBs that result from necrosis (e.g., hypoxic cores; Figure 2A and Supplementary Movies 2–5). Images corresponding to PI fluorescence in orthogonal sections of EBs (i.e., z-axis stacks) were acquired using CLSM and typically 50–80 sections that encompassed the entire depth of the EB (48.38 ± 4.20 μm, n = 14 EBs) were acquired. Z-axis image stacks were reconstructed into 360° rotational views of EB structure using Imaris 6.0 (Bitplane). Three-dimensional reconstructions of EBs at 0, 1, 2, and 3 weeks are given in Supplementary Movies 2–5, respectively.
EB randomization and disaggregation
Three days following the transfer of EBs to U-bottom plates (Day 8, Figure 1A), EBs were scored according to their morphological status and those EBs characterized by well-defined structure were randomly assigned dates for subsequent disaggregation using a computerized random number generator. This randomization time point marked the start of the second phase of the protocol—a 4-week scheme designed to investigate the effect of maturation in EB vs. “on plate” culture [weeks 0 to 4; (Figure 1B)].
Randomized EBs differentiated from the same batch of iPS (Bilican et al., 2012) were disaggregated at half-week intervals using 0.05% trypsin solution (Life Technologies) at 37°C for 2 min. Next, dissociation solution [0.05% trypsin solution (20%), cell dissociation buffer (40%), RPMI (40%)] was added to each well before further incubation for 6 min at 37°C. Well contents were transferred to 1.5 ml centrifugation tubes (2 EBs per tube) and the suspension was centrifuged (400 × g, 3 min). The pellet was re-suspended in RPMI-ITS and then transferred to a 0.1% (w/v) gelatin-coated 14 mm glass-bottomed plate (Mattek Corporation). Plates corresponding to a unique time point in the experimental matrix (Figure 1B) were set up in triplicate and IPS-CM in this “on plate” configuration were maintained in RPMI-ITS. In some experiments, IPS-CM populations in a 0.65 mm2 field of view (FOV) were tracked over an initial 48 h period post-plating using time-lapse imaging. Images were acquired every 20 min using an in-incubator microscope fitted with a 10x objective and FOV illumination via a white-light LED (Lumascope, Etaluma) remotely controlled by Lumaview software.
Ca2+ imaging
At half-week intervals throughout the 4-week protocol (Figure 1B, diagonal), plates containing IPS-CM were washed with low [Ca2+] Tyrode's solution (LCTS, containing (in mM): NaCl (140), KCl (5.4), CaCl2 (0.4), MgCl2 (1), HEPES (10), and glucose (10); pH 7.4) and then incubated with LCTS containing fluo4-AM (5 μM, diluted from a freshly prepared 1 mM stock dissolved in DMSO without F-127 pluronic acid; Life Technologies) for 20 min at 37°C, conditions that result in homogeneous loading of cells' cytoplasm and nucleus and not intracellular organelles. LCTS and RPMI1640 both contain free [Ca2+] at ~0.4 mM. Imaging of user-defined areas containing IPS-CM clusters was performed using CLSM and a 63X oil-immersion objective (numerical aperture (NA) 1.4) (SP5, Leica Microsystems). Fluorescence and the corresponding brightfield images in B-areas (0.021 mm2; Figure 4A) were acquired at 512 × 512 pixel resolution at 14.7 frames per second as described (Lewis et al., 2015). After imaging Ca2+-dependent fluo4 signals in IPS-CM clusters under basal (non-stimulated) conditions for 330 s, a bolus of CaCl2 was added to raise extracellular [Ca2+] to ~1.8 mM and imaging was continued for 210 s (Figure 1C). Following Ca2+ imaging, plates were fixed using formaldehyde [4% (v/v) in PBS] and IPS-CM nuclei were counter-stained with DAPI (300 nM in PBS, 2 min). Subsequently, five random A-areas of each plate were imaged using a 10X objective [A-areas (0.923 mm2), Figure 4A].
Quantifying regional Ca2+ synchronization and the temporal organization of Ca2+ spikes in IPS-CM clusters
Image series obtained from B-areas (0.021 mm2) were subdivided into square grids comprised of 49 identical regions of interest (7 × 7 C-areas, each 0.00043 mm2; Figure 4A). For each component C-area, the signal intensity traces, corresponding to changes in Ca2+-dependent fluo4 fluorescence with time, were exported using LAS-AF Report function (Leica Microsystems) and transferred into Matlab (MathWorks, Inc). Data were de-trended and super-threshold Ca2+ signal events (“spikes”) were detected using a custom-made algorithm that calculates local maximum of the first derivative (i.e., Ca2+ spikes correspond to the local maximum positive gradient (dF/dt) in the signal where F = fluorescence signal intensity and t = time).
To compute the extent of Ca2+ synchronization within a B-area, the temporal organization of Ca2+ spikes across the component 49 C-areas was calculated (Figure 4A). The perfect temporal co-incidence of Ca2+ spikes in one C-area with those in another C-area generates a straight line with a correlation co-efficient (R-value) of 1. We considered an R-value of ≥ 0.85 as a stringent threshold for robust correlation. For each C-area, the number of the other 48 C-areas that exhibited temporally co-incident Ca2+ spikes that met this criterion of an R-value ≥ 0.85 was calculated. This process was iterated through all 49 C-areas in the 7 × 7 grid. The extent of regional Ca2+ synchronization was thus defined as the proportion of a B-area that exhibited co-incident (synchronized) Ca2+ spikes and was expressed as a physical area (μm2). Regional Ca2+ synchronization in B-areas was visualized by linear interpolation and then assigned a pseudo-color look-up table that spanned the range of values determined.
The temporal organization of Ca2+ spikes in C-areas was also used to calculate the mean inter-spike interval (ISI) and the standard deviation of ISI [defined as the temporal heterogeneity index (THI); Lewis et al., 2015; Figure 6A]. The numerical value of THI increase as the Ca2+ spikes become more temporally disordered (Lewis et al., 2015).
Assessment of IPS-CM density, plating heterogeneity, and Troponin-T distribution
The density and plating heterogeneity of IPS-CM were calculated from data obtained from five random A-areas on each plate (Figure 4A). Cell densities in B-areas (Figure 4A) were calculated from the same IPS-CM clusters that had been user-selected for Ca2+ imaging. Plating heterogeneity was defined as the standard deviation of regional cell density in A- and B-areas normalized to the corresponding value obtained immediately following the disaggregation of 0-week EBs, which was assigned 1.
To determine the intracellular distribution of troponin-T, IPS-CM were fixed, permeabilized and incubated with a mouse anti-rabbit troponin-T monoclonal IgG which cross reacts with human cardiac troponin-T (clone 13-11, Life Technologies) as described (Lewis et al., 2015). Immunodetection of anti-troponin T antibodies was performed using an Alexa-594 conjugated donkey anti-mouse IgG (Life Technologies) diluted 1:500 (v/v) in PBS. Cell nuclei were counter-stained using DAPI (300 nM in PBS, 2 min).
Ethics statement
This work used serially passaged iPS lines that had been generated at the MRC Centre for Regenerative Medicine, University of Edinburgh. All protocols were fully compliant with local and national guidelines and legislation.
Results
Physical characterization of EBs
The differentiation process adapted from Burridge et al. (2011; Figure 1A) yielded a high proportion of spontaneously-beating EBs [351/480 (73.1%)] and the frequency of beating remained remarkably consistent over 4 weeks (0.24 ± 0.06 Hz, p = 0.17, n = 23 EBs) (Supplementary Movie 1). The shape of all EBs approximated to flat cylinders (ratio of diameter-to-height = 15.76 ± 2.30, n = 9 EBs), the physical dimensions of which did not change over the study. Although there was evidence of a progressive time-dependent change in cellular arrangement within EBs (Figure 2A and Supplementary Movies 2–5), the total EB volume (0.018 ± 0.003 mm3, n = 9 EBs; Figure 2B) and the volume of the EB that could be ascribed to PI-stained IPS-CM (Figure 2C) remained unchanged (non-parametric ANOVA yielded p = 0.57 and p = 0.28 for these parameters over the 4-week period, respectively). In three-dimensional reconstructions of EBs we did not observe cavitation or the formation of acellular hypoxic cores (which would not be stained by PI) over the course of the study (Supplementary Movies 2–5).
EB randomization, disaggregation, and “On Plate” culture of IPS-CM
Of the spontaneously beating EBs, 330 were selected for subsequent randomization and disaggregation according to the experimental matrix (Figure 1B). Following the disaggregation of 0–3.5 week old EBs via a gentle dissociation protocol designed to retain small CM clusters [see Section Materials and Methods and Figures 3A,B, 4A(ii)], time-lapse imaging revealed that in the first 48 h after seeding onto gelatin-coated glass, the majority of adherent post-EB IPS-CM exhibited dynamic changes in shape and migrated across the culture surface (Figures 3A,B, Supplementary Movies 6, 7). The number of IPS-CM that initially adhered to the gelatin-coated surface (i.e., within the first 6 h of seeding) was reduced following the disaggregation of older EBs (Figure 3C). In all adherent IPS-CM populations the extent of cell death as determined by PI- and Trypan Blue exclusion assays (George et al., 2003) was very low (< 0.5%) and there was no association between the extent of cell death and the age of the dissociated EB (r2 = 0.03). Likewise, mitotic capacity in post-EB IPS-CM was extremely low (0.01%) and we recorded just one incidence of cell division during the entire study (Figure 3A, white boxed area; Supplementary Movie 8 between 1040 and 1060 min).
We used a grid system of three differentially sized areas (A-, B-, and C- areas; see Section Materials and Methods) to analyse IPS-CM density and distribution following EB disaggregation (Figure 4A and Section Materials and Methods). After ~1 week in culture, all IPS-CM clusters were characterized by well-demarked troponin-T striation [Figure 4A(iii)] and there were no detectable time- or culture-dependent differences in cell shape, size or troponin-T distribution beyond this time. Entirely consistent with our finding that the disaggregation of older EBs was associated with poorer initial adherence of IPS-CMs to gelatin-coated glass (Figure 3C), we determined a weak negative correlation between the density of IPS-CM in A- and B- areas and the age of the EB at disaggregation (Figures 4B,C). Corroborating this finding, the plating heterogeneity, an index in which a larger number describes an increased heterogeneity of IPS-CM dispersal, increased markedly when IPS-CM were disaggregated from EBs > 2 weeks old (Figure 4D). The links apparent between the disaggregation of older EBs, reduced IPS-CM densities and the increased plating heterogeneity were also reinforced by the demonstration of a robust linear relationship between the sparseness of IPS-CM and the age of the EB at disaggregation (Figure 4E).
Ca2+ signaling in IPS-CM clusters following EB disaggregation
We sought to determine whether the maturation of IPS-CM in EBs or “on plate” culture affected Ca2+ spike synchronization in IPS-CM clusters and focussed our analysis to the study of IPS-CM clusters in B-areas [arrowed, Figure 4A(ii)]. CLSM imaging of fluo4-dependent Ca2+ signaling in post-EB IPS-CM clusters (Figure 5A) was used to compile maps of regional Ca2+ synchronization across entire B-areas (Figure 5B). The plating of IPS-CM dissociated prior to any appreciable maturation phase in EB (i.e., maturation in EB = 0 weeks, vertical), or those from EBs > 2 weeks old, resulted in IPS-CM clusters that rarely supported spontaneous Ca2+ oscillations (Figures 5C,D). In contrast, the disaggregation of EBs between 0.5 to 1.5 weeks resulted in IPS-CM clusters characterized by high levels of spontaneous activity and regional Ca2+ synchronization (Figures 5C,D). A unifying feature of those IPS-CMs disaggregated from 0.5 to 1.5 week old EBs was the subsequent loss of spontaneous Ca2+ oscillations with continued “on plate” culture (Figures 5C,D, verticals).
We also determined the temporal organization of Ca2+ spikes in the component C-areas using two indices, the inter-spike interval (ISI) and temporal heterogeneity index (THI) (Figure 6A), the latter increasing with increased temporal disordering of Ca2+ spikes in IPS-CM (Lewis et al., 2015). Consistent with the reduced regional Ca2+ synchronization in those IPS-CM clusters derived from EBs > 2 weeks old (Figures 5C,D, 6B, upper panel), ISI and THI were elevated in IPS-CM derived from these older EBs (Figure 6B, middle and lower panels, respectively). In contrast, although “on plate” culture was linked to progressive loss of regional Ca2+ synchronization in those IPS-CM exhibiting spontaneous activity on initial plating (Figures 5C,D, 6C, top panel), this phenomenon was not linked to the ISI and THI indices which remained unchanged over the time of IPS-CM “on plate” culture (Figure 6C, middle and lower panels, respectively). Taking all data together, there was a negative correlation between ISI and THI and the extent of regional Ca2+ synchronization (Figures 7A,B, respectively), suggesting that higher levels of regional Ca2+ synchronization were associated with lower ISI (Figure 7A) and THI values (Figure 7B; i.e., better organized Ca2+ spikes).
IPS-CM quiescence and the differential effects of increased [Ca2+]ext
The proportion of spontaneously active post-EB IPS-CM clusters was dependent on the time of maturation of the IPS-CM within EBs with those typically dissociated from EBs between 0.5 and 1.5 weeks having the highest proportion of spontaneous Ca2+ spiking activity. Like the progressive reduction in the extent of regional Ca2+ synchronization in these IPS-CM clusters (Figures 5C,D), the reduced ability to support spontaneous Ca2+ spikes was a common feature of IPS-CM maintained “on plate” (Figure 8A). To explore this in more detail, we investigated the responsiveness of these IPS-CMs that had become non-oscillatory (“quiescent”) either as a result of “on plate” culture or those IPS-CM that typically did not exhibit inherent spontaneous Ca2+ spiking activity (i.e., those derived from EBs > 2 weeks old; Figures 5C,D, 8A) to raised extracellular Ca2+ ([Ca2+]ext). This protocol, in which [Ca2+]ext was raised from ~0.4 mM to 1.8 mM, unmasked strikingly different responses in these quiescent IPS-CM. In some IPS-CM the increased [Ca2+]ext triggered a large elevation in intracellular [Ca2+] which lasted for several minutes (Figures 8B,C). In others it provoked sustained high-amplitude Ca2+ oscillations around an elevated intracellular [Ca2+] (Figures 8D,E). The differential responses of IPS-CM clusters to increased [Ca2+]ext mapped to whether their quiescence was inherent or culture-induced and were separable in the experimental matrix (Figure 8C vs. Figure 8E).
The data shown in Figure 8, together with the quantification of regional Ca2+ synchronization (Figures 5–7), were used to compile a distribution map of spontaneously-active Ca2+-synchronized IPS-CM and those IPS-CM clusters which exhibited innate or culture-dependent quiescence and which responded differently to increased [Ca2+]ext (Figure 9).
Discussion
We investigated the extent of regional Ca2+ synchronization in clusters of human IPS-CM that had been derived from EBs vs. those maintained in post-EB “on plate” culture over 4-weeks (Figure 1B). Intercellular Ca2+ synchronization across cell populations is collectively determined by multiple coupled oscillators acting across multiple scales (Novák and Tyson, 2008; Kholodenko et al., 2010; Kim et al., 2010a; Lakatta et al., 2010; George et al., 2012; Boileau et al., 2015) and thus the quantification of regional Ca2+ synchronization represents a robust index of IPS-CM functional competency. This study shows that tracking the changes in IPS-CM Ca2+ synchronization through two methods of maturation (EB vs. “on plate”) gives insights into some of the culture-dependent determinants that modulate IPS-CM Ca2+ handling behavior.
Cardiac cell signaling in vivo is modulated by interactions with neighboring cells and many approaches for directing cardiomyocyte maturation via the control of cell-to-cell communication have been developed (Tulloch et al., 2011; McSpadden et al., 2012; Tian and Morrisey, 2012; Zhang et al., 2012; Rao et al., 2013; Thavandiran et al., 2013; Howard and Baudino, 2014; Yang et al., 2014). An important factor in the present work therefore was the optimization of a gentle EB-disaggregation process that preserved the integrity of cell-to-cell contacts in the resulting IPS-CM clusters. These methods resulted in post-EB disaggregated IPS-CM clusters [arrowed, Figures 3A, 4A(ii)] that exhibited spontaneous rates of beating comparable to those of the source EBs.
The absence of regional Ca2+ synchronization (Figure 5D), spontaneous Ca2+ oscillation (Figure 8A) and the lack of response to elevated [Ca2+]ext (Figures 8C,E) in those IPS-CM disaggregated from 0 week EBs are consistent with the view that CM maturation in the EB phase for even a very short time is a prerequisite for developing Ca2+-handling competency in IPS-CM populations.
IPS-CM clusters derived from EBs at 0.5–1.5 weeks exhibited the highest levels of regional Ca2+ synchronization (Figure 5D) and spontaneous Ca2+ oscillation activity (Figure 8A). The latter characteristic is a hallmark of immature cardiomyocyte phenotype and these data suggest that whilst 0.5–1.5 weeks in EB is sufficient to develop Ca2+ signaling competency, these IPS-CM are not functionally mature (adult-like) cardiomyocytes. Importantly, maintenance of these IPS-CM under “on plate” conditions was associated with the progressive elimination of regional Ca2+ synchronization (Figure 5D) and the loss of spontaneous Ca2+ oscillations (Figure 8A). There are numerous factors that potentially contribute to the cessation of spontaneous Ca2+ oscillations in IPS-CM obtained from 0.5 to 1.5 week EBs following “on plate” culture and this issue warrants further investigation. However, we can eliminate the influence of the low [Ca2+] environment. RPMI-based media containing relatively low [Ca2+] (~0.4 mM) was used throughout this study and the spontaneous contractility observed in EBs across the 4-week protocol reveals that 0.4 mM [Ca2+]ext is fully compatible with the development and persistence of spontaneous Ca2+ oscillations. It is plausible however that the comparatively low extracellular Ca2+ environment used in Burridge's protocol (Burridge et al., 2011) does influence some aspects of EB development and function. IPS-CM morphology, shape, density and viability remained unchanged during “on plate” culture but it is possible that cell maintenance in this configuration for up to 3.5 weeks does alter the profile of atrial, nodal or ventricular-type activities within the IPS-CM population. A more in-depth exploration of this issue is needed. Since we have argued above that one of the key features marking the transition from immature to mature cardiomyocyte phenotype is the loss of spontaneous Ca2+ oscillatory behavior, we propose that “on plate” post-EB culture may be associated with the development of a more mature IPS-CM phenotype. This conclusion, which is well aligned with methodological developments aimed at monolayer-oriented protocols (van den Berg et al., 2016), and extends previous reports of CM maturation in EBs (Snir et al., 2003; Burridge et al., 2011), is supported by our demonstration of the re-emergence of well-ordered Ca2+ oscillations in these “on plate”-induced “Ca2+ quiescent” IPS-CM populations following an increase in [Ca2+]ext and points to their comparatively mature Ca2+ handling machinery. It should be noted that the increased [Ca2+]ext used in these experiments (~1.8 mM) does not represent a “physiologically” high Ca2+ environment ([Ca2+]ext in vivo is around 1.3 mM; Bers, 2001) but it is substantially higher than the comparatively low [Ca2+]ext that the EB and IPS-CM are maintained in (~0.4 mM).
At the molecular level, the development of a more mature ventricular-like cardiomyocyte phenotype during “on plate” culture is consistent with the loss of the components that promote automaticity (e.g., reduced expression of pace-making HCN (IKf, funny current) and T-type Ca2+ channels (Lakatta and DiFrancesco, 2009; Lakatta et al., 2010) and the possible re-balancing of “voltage clocks” and “Ca2+ clocks” (Weisbrod et al., 2013). This remains to be investigated in these IPS-CM clusters. We cannot exclude the possibility that a recovery of spontaneous Ca2+ oscillatory activity in these IPS-CM clusters occurs beyond the 4-week period of this study and thus a longer-term assessment of IPS-CM Ca2+ signaling is now warranted. The use of genetically encoded Ca2+ indicators (Kaestner et al., 2014) that enable the non-invasive tracking of Ca2+ signaling events over much longer time periods would facilitate such an approach.
In contrast to the spontaneous activities of IPS-CM derived from EBs between 0.5 and 1.5 weeks, the disaggregation of EBs older than 2 weeks resulted in a decreased number of adherent, spontaneously active IPS-CM (Figure 3). The physical dimensions and cellular occupancy of the source EBs remained comparatively constant over 4 weeks (Figure 2) and there was no evidence of cavitation or necrotic cores as has been reported by others (Gothard et al., 2009; Pettinato et al., 2014) (see Supplementary Movies 2–5). Furthermore, the decreased number of dissociated IPS-CM was not due to reduced post-EB cell proliferation since the extent of cell division following the disaggregation of all EBs was extremely low and we recorded just one cell division event during the entire study (Supplementary Movie 8). Thus, in our view, the most likely explanation for the decreased numbers of IPS-CM following disaggregation of later EBs (>2 weeks) is that changes in the nature of intercellular coupling via modulation of gap junction (connexin), tight-junction (ZO-1 and 2) and adherens junction proteins with EB maturation (Oyamada et al., 1996; Komura et al., 2008; Phua et al., 2014; Pettinato et al., 2015) limits the efficiency of IPS-CM dissociation from older EBs. The notion of enhanced cell-to-cell coupling in these older EBs is supported by the comparative functional “adult-like” maturity of the resulting IPS-CM clusters which typically lack spontaneous oscillatory behavior (Figure 8A) yet respond to elevated [Ca2+]ext (Figures 8D,E).
Of relevance to arguments regarding the functional maturation of IPS-CM, it should be noted that all post-EB IPS-CM clusters were characterized by intracellular striation of troponin-T [Figure 4A(iii)]. Since IPS-CM studied in these investigations exhibited a broad range of Ca2+ handling synchronization and spontaneous activity across a 4-week period, our data would suggest that whilst troponin-T labeling remains an extensively used immunomarker of cardiomyocytes, it does not discriminate the maturity of the cardiomyocytes (Gorza et al., 1996; Sheng et al., 2012; Khan et al., 2013). This finding concurs with our previous data that showed that troponin-T immunoreactivity and striation per se is not a good index of the functional maturity of the Ca2+ handling machinery in human ES-derived cardiomyocytes (Lewis et al., 2015).
One of the most striking findings of these investigations is that IPS-CM devoid of the capacity to support spontaneous Ca2+ oscillations either innately or as a consequence of “on plate” culture responded differently to elevated [Ca2+]ext (Figure 8). From these data, a picture thus emerges in which similar IPS-CM phenotypes (e.g., comparable Ca2+ handling, morphologies, densities and ages) underscored by different modes of derivation (e.g., EB vs. “on plate”) can result in very different response to external cues (e.g., elevated [Ca2+]ext). Spontaneous and Ca2+-triggered behavior in IPS-CM clusters can be traced back to their route of derivation and therefore a major finding of this study is that adaptive changes in Ca2+-signal organization under different maturation conditions are determinants of IPS-CM behavior. This finding is entirely in agreement with reports that cell function and fate may be imprinted via early-stage genetic and epigenetic events (Beqqali et al., 2006; Kim et al., 2010b; Balázsi et al., 2011; Li et al., 2012; Cahan et al., 2014; Morris et al., 2014). Our data also support the intriguing possibility that IPS-CM responses can be predicted from a detailed knowledge of their routes of derivation and maturation. In this proof-of-concept study, we focussed on the analysis of Ca2+ signal organization as a means to systematically track the functional maturation of Ca2+ synchronization in IPS-CM following in EBs vs. “on plate” culture. Further work is currently underway to determine whether such an approach can be utilized to explore other endpoints including ion channel expression profile, selective responses to drugs (e.g., to β-adrenoceptor antagonists, Ca2+-sensitizers) and IPS-CM tolerance to massive scale culturing required to generate the vast numbers of cells required for heterologous and autologous cellular transplantation in new heart repair approaches (Mummery et al., 2010; Khan et al., 2013).
Funding
This work was funded by the British Heart Foundation (FS/09/028/27602; RG/09/009/28069; CH/06/002/21631), Wellcome Trust (094219/Z/10/Z), and the Wales Deanery (School of Postgraduate Medical and Dental Education).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
We thank Dr. Siddharthan Chandran (MRC Centre for Regenerative Medicine, University of Edinburgh) for providing the iPS.
Supplementary material
The Supplementary Material for this article can be found online at: http://journal.frontiersin.org/article/10.3389/fcell.2015.00089
References
- Balázsi G., van Oudenaarden A., Collins J. J. (2011). Cellular decision making and biological noise: from microbes to mammals. Cell 144, 910–925. 10.1016/j.cell.2011.01.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beqqali A., Kloots J., Ward-van Oostwaard D., Mummery C., Passier R. (2006). Genome-wide transcriptional profiling of human embryonic stem cells differentiating to cardiomyocytes. Stem Cells 24, 1956–1967. 10.1634/stemcells.2006-0054 [DOI] [PubMed] [Google Scholar]
- Bers D. M. (2001). Excitation-Contraction Coupling and Contractile Force. Dordrecht; Boston, MA; London: Kluwer Academic Publishers. [Google Scholar]
- Bilican B., Serio A., Barmada S. J., Nishimura A. L., Sullivan G. J., Carrasco M., et al. (2012). Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc. Natl. Acad. Sci. U.S.A. 109, 5803–5808. 10.1073/pnas.1202922109 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boileau E., George C. H., Parthimos D., Mitchell A. N., Aziz S., Nithiarasu P. (2015). Synergy between intercellular communication and intracellular Ca2+ handling in arrhythmogenesis. Ann. Biomed. Engin. 43, 1614–1625. 10.1007/s10439-014-1243-x [DOI] [PubMed] [Google Scholar]
- Braam S. R., Tertoolen L., van de Stolpe A., Meyer T., Passier R., Mummery C. L. (2010). Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res. 4, 107–116. 10.1016/j.scr.2009.11.004 [DOI] [PubMed] [Google Scholar]
- Burridge P. W., Thompson S., Millrod M. A., Weinberg S., Yuan X., Peters A., et al. (2011). A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS ONE 6:e18293. 10.1371/journal.pone.0018293 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cahan P., Li H., Morris S. A., Lummertz da Rocha E., Daley G. Q., Collins J. J. (2014). CellNet: network biology applied to stem cell engineering. Cell 158, 903–915. 10.1016/j.cell.2014.07.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carvajal-Vergara X., Sevila A., D'souza S. L., Ang Y.-S., Schaniel C., Lee D.-F., et al. (2010). Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465, 808–812. 10.1038/nature09005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Caspi O., Huber I., Gepstein A., Arbel G., Maizels L., Boulos M., et al. (2013). Modelling of arrhythmogenic right ventricular cardiomyopathy with human-induced pluripotent stem cells. Circ. Cardiovasc. Genet. 6, 557–568. 10.1038/nature11799 [DOI] [PubMed] [Google Scholar]
- Dambrot C., Passier R., Atsma D., Mummery C. L. (2011). Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models. Biochem. J. 434, 25–35. 10.1042/BJ20101707 [DOI] [PubMed] [Google Scholar]
- Dick E., Rajamohan D., Ronksley J., Denning C. (2010). Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening. Biochem. Soc. Trans. 38, 1037–1045. 10.1042/bst0381037 [DOI] [PubMed] [Google Scholar]
- Dolnikov K., Shilkrut M., Zeevi-Levin N., Gerecht-Nir S., Amit M., Danon A., et al. (2006). Functional properties of human embryonic stem cell-derived cardiomyocytes: intracellular Ca2+ handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells 24, 236–245. 10.1634/stemcells.2005-0036 [DOI] [PubMed] [Google Scholar]
- George C. H., Martin P. E. M., Evans W. H. (1998). Rapid determination of gap junction formation using HeLa cells microinjected with cDNAs encoding wild-type and chimeric connexins. Biochem. Biophys. Res. Commun. 247, 745–789. 10.1006/bbrc.1998.8835 [DOI] [PubMed] [Google Scholar]
- George C. H., Higgs G. V., Mackrill J. J., Lai F. A. (2003). Dysregulated ryanodine receptors mediate cellular toxicity: restoration of normal phenotype by FKBP12.6. J. Biol. Chem. 278, 28856–28864. 10.1074/jbc.m212440200 [DOI] [PubMed] [Google Scholar]
- George C. H., Parthimos D., Silvester N. C. (2012). A network-oriented perspective on cardiac calcium signaling. Am. J. Physiol. Cell Physiol. 303, C897–C910. 10.1152/ajpcell.00388.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gorza L., Menabo R., Vitadello M., Bergamini C. M., Di Lisa F. (1996). Cardiomyocyte troponin T immunoreactivity is modified by cross-linking resulting from intracellular calcium overload. Circulation 93, 1896–1904. 10.1161/01.CIR.93.10.1896 [DOI] [PubMed] [Google Scholar]
- Gothard D., Roberts S. J., Shakesheff K. M., Buttery L. (2009). Controlled embryoid body formation via surface modification and avidin-biotin cross-linking. Cytotechnology 61, 135–144. 10.1007/s10616-010-9255-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harris K., Aylott M., Cui Y., Louttit J., McMahon N. C., Sridhar A. (2013). Comparison of electrophysiological data from human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) to functional pre-clinical safety assays. Toxicol. Sci. 134, 412–426. 10.1093/toxsci/kft113 [DOI] [PubMed] [Google Scholar]
- Howard C. M., Baudino T. A. (2014). Dynamic cell-cell and cell-ECM interactions in the heart J. Mol. Cell. Cardiol. 70, 19–26. 10.1016/j.yjmcc.2013.10.006 [DOI] [PubMed] [Google Scholar]
- Itzhaki I., Maizels L., Huber I., Zwi-Dantsis L., Caspi O., Winterstern A., et al. (2011a). Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471, 225–229. 10.1038/nature09747 [DOI] [PubMed] [Google Scholar]
- Itzhaki I., Rapoport S., Huber I., Mizrahi I., Zwi-Dantsis L., Arbel G., et al. (2011b). Calcium handling in human induced pluripotent stem cell derived cardiomyocytes. PLoS ONE 6:e18037. 10.1371/journal.pone.0018037 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Itzhaki I., Maizels L., Huber I., Gepstein A., Arbel G., Caspi O., et al. (2012). Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells. J. Am. Coll. Cardiol. 60, 990–1000. 10.1016/j.jacc.2012.02.066 [DOI] [PubMed] [Google Scholar]
- Jung C. B., Moretti A., Mederos y Schnitzler M., Iop L., Storch U., Bellin M., et al. (2012). Dantrolene rescues arrhythmogenic RyR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Mol. Med. 4, 180–191. 10.1002/emmm.201100194 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kaestner L., Scholz A., Tian Q., Ruppenthal S., Tabellion W., Wiesen K., et al. (2014). Genetically encoded Ca2+ indicators in cardiac myocytes. Circ. Res. 114, 1623–1639. 10.1161/circresaha.114.303475 [DOI] [PubMed] [Google Scholar]
- Khan J. M., Lyon A. R., Harding S. E. (2013). The case for induced pluripotent stem cell-derived cardiomyocytes in pharmacological screening. Br. J. Pharmacol. 169, 304–317. 10.1111/j.1476-5381.2012.02118.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kholodenko B. N., Hancock J. F., Kolch W. (2010). Signalling ballet in space and time. Nat. Rev. Mol. Cell Biol. 11, 414–426. 10.1038/nrm2901 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim J.-R., Shin D., Jung S. H., Heslop-Harrison P., Cho K.-H. (2010a). A design principle underlying the synchronization of oscillations in cellular systems. J. Cell. Sci. 123, 537–543. 10.1242/jcs.060061 [DOI] [PubMed] [Google Scholar]
- Kim K., Doi A., Wen B., Ng K., Zhao R., Cahan P., et al. (2010b). Epigenetic memory in induced pluripotent stem cells. Nature 467, 285–290. 10.1038/nature09342 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Komura H., Ogita H., Ikeda W., Mizoguchi A., Miyoshi J., Takai Y. (2008). Establishment of cell polarity by afadin during the formation of embryoid bodies. Genes Cells 13, 79–90. 10.1111/j.1365-2443.2007.01150.x [DOI] [PubMed] [Google Scholar]
- Lakatta E. G., DiFrancesco D. (2009). What keeps us ticking: a funny current, a calcium clock, or both? J. Mol. Cell. Cardiol. 47, 157–170. 10.1016/j.yjmcc.2009.03.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lakatta E. G., Maltsev V., Vinogradova T. M. (2010). A coupled SYSTEM of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart's pacemaker. Circ. Res. 106, 659–673. 10.1161/circresaha.109.206078 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lalit P. A., Hei D. J., Raval A. N., Kamp T. J. (2014). Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges. Circ. Res. 114, 1328–1345. 10.1161/circresaha.114.300556 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lan F., Lee A. S., Liang P., Sanchez-Freire V., Nguyen P. K., Wang L., et al. (2013). Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cells 12, 101–113. 10.1016/j.stem.2012.10.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lewis K. J., Silvester N. C., Barberini-Jammaers S., Mason S. A., Marsh S. A., Lipka M., et al. (2015). A new system for profiling drug-induced calcium signal perturbation in human embryonic stem cell-derived cardiomyocytes. J. Biomol. Screen. 20, 330–340. 10.1177/1087057114557232 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li M., Liu G.-H., Belmonte J. C. I. (2012). Navigating the epigenetic landscape of pluripotent stem cells. Nat. Rev. Mol. Cell Biol. 13, 524–535. 10.1038/nrm3393 [DOI] [PubMed] [Google Scholar]
- Li S., Chen G., Li R. A. (2013). Calcium signalling of human pluripotent stem cell-derived cardiomyocytes. J. Physiol. 591, 5279–5290. 10.1113/jphysiol.2013.256495 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liang P., Lan F., Lee A. S., Gong T., Sanchez-Freire V., Wang Y., et al. (2013). Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation 127, 1677–1691. 10.1161/CIRCULATIONAHA.113.001883 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martin R. M., Leonhardt H., Cardoso M. C. (2005). DNA labeling in living cells. Cytometry A 67, 45–52. 10.1002/cyto.a.20172 [DOI] [PubMed] [Google Scholar]
- Masumoto H., Ikuno T., Takeda M., Fukushima H., Marui A., Katayama S., et al. (2014). Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration. Sci. Rep. 4:6716. 10.1038/srep06716 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Matsa E., Rajamohan D., Dick E., Young L., Mellor I., Staniforth A., et al. (2011). Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. Eur. Heart J. 32, 952–962. 10.1093/eurheartj/ehr073 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Matsa E., Dixon J. E., Medway C., Georgiou O., Patel M. J., Morgan K., et al. (2014). Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes. Eur. Heart J. 35, 1078–1087. 10.1093/eurheartj/eht067 [DOI] [PMC free article] [PubMed] [Google Scholar]
- McSpadden L. C., Nguyen H., Bursac N. (2012). Size and ionic currents of unexcitable cells coupled to cardiomyocytes distinctly modulate cardiac action potential shape and pacemaking activity in micropatterned cell pairs. Circ. Arrhythm. Electrophysiol. 5, 821–830. 10.1161/circep.111.969329 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mercola M., Colas A., Williems E. (2013). Induced pluripotent stem cells in cardiovascular drug discovery. Circ. Res. 112, 534–548. 10.1161/circresaha.111.250266 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Minami I., Yamada K., Otsuji T. G., Yamamoto T., Shen Y., Otsuka S., et al. (2012). A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. Cell Rep. 2, 1448–1460. 10.1016/j.celrep.2012.09.015 [DOI] [PubMed] [Google Scholar]
- Mitalipova M. M., Rao R. R., Hoyer D. M., Johnson J. A., Meisner L. F., Jones K. L., et al. (2005). Preserving the genetic integrity of human embryonic stem cells. Nat. Biotechnol. 23, 19–20. 10.1038/nbt0105-19 [DOI] [PubMed] [Google Scholar]
- Moretti A., Bellin M., Welling A., Jung C. B., Lam J. T., Bott-Flugel L., et al. (2010). Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363, 1397–1409. 10.1056/NEJMoa0908679 [DOI] [PubMed] [Google Scholar]
- Morris S. A., Cahan P., Li H., Zhao A. M., San Roman A. K., Shivdasani R. A., et al. (2014). Dissecting engineered cell types and enhancing cell fate conversion via CellNet. Cell 158, 889–902. 10.1016/j.cell.2014.07.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mummery C. L., Davis R. P., Krieger J. E. (2010). Challenges in using stem cells for cardiac repair. Sci. Trans. Med. 2:27ps17. 10.1126/scitranslmed.3000558 [DOI] [PubMed] [Google Scholar]
- Mummery C. L., Zhang L., Ng E. S., Elliott D. A., Elefanty A. G., Kamp T. J. (2012). Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ. Res. 111, 344–358. 10.1161/circresaha.110.227512 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakamura N., Yamazawa T., Okubo Y., Iino M. (2009). Temporal switching and cell-to-cell variability in Ca2+ release activity in mammalian cells. Mol. Syst. Biol. 5, 247. 10.1038/msb.2009.6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Novák B., Tyson J. J. (2008). Design principles of biochemical oscillators. Nat. Rev. Mol. Cell Biol. 9, 981–991. 10.1038/nrm2530 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Oh Y., Wei H., Ma D., Sun X., Liew R. (2012). Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine. Heart 98, 443–449. 10.1136/heartjnl-2011-301317 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Oyamada Y., Komatsu K., Kimura H., Mori M., Oyamada M. (1996). Differential regulation of gap junction protein (connexin) genes during cardiomyocytic differentiation of mouse embryonic stem cells in vitro. Exp. Cell Res. 229, 318–326. [DOI] [PubMed] [Google Scholar]
- Park I.-H., Zhao R., West J. A., Yabuuchu A., Huo H., Ince T. A., et al. (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141–146. 10.1038/nature06534 [DOI] [PubMed] [Google Scholar]
- Pettinato G., Wen X., Zhang N. (2014). Formation of well-defined embyroid bodies from dissociated human induced pluripotent stem cells using microfabricated cell-repellent microwell arrays. Sci. Rep. 4:7402. 10.1038/srep07402 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pettinato G., Wen X., Zhang N. (2015). Engineering strategies for the formation of embryoid bodies from human pluripotent stem cells. Stem Cells Dev. 24, 1595–1609. 10.1089/scd.2014.0427 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Phua D. C., Xu J., Ali S. M., Boey A., Gounko N. V., Hunziker W. (2014). ZO-1 and ZO-2 are required for extra-embryonic endoderm integrity, primitive ectoderm survival and normal cavitation in embryoid bodies derived from mouse embryonic stem cells. PLoS ONE 9:e99532. 10.1371/journal.pone.0099532 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rao C., Prodromakis T., Kolker L., Chaudhary U. A. R., Trantidou T., Sridhar A., et al. (2013). The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells. Biomaterials 34, 2399–2411. 10.1016/j.biomaterials.2012.11.055 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Savla J. J., Nelson B. C., Perry C. N., Adler E. D. (2014). Induced pluripotent stem cells for the study of cardiovascular disease. J. Am. Coll. Cardiol. 64, 512–519. 10.1016/j.jacc.2014.05.038 [DOI] [PubMed] [Google Scholar]
- Sheng X., Reppel M., Nguemo F., Mohammed F. I., Kuzmenkin A., Hescheler J., et al. (2012). Human pluripotent stem cell-derived cardiomyocytes: response to TTX and lidocain reveals strong cell to cell variability. PLoS ONE 7:e45963. 10.1371/journal.pone.0045963 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Silvester N. C., George C. H. (2011). Searching for new cardiovascular drugs: towards improved systems for drug screening? Expert Opin. Drug Discov. 6, 1155–1170. 10.1517/17460441.2011.625652 [DOI] [PubMed] [Google Scholar]
- Sinnecker D., Goedel A., Laugwitz K.-L., Moretti A. (2013). Induced pluripotent stem cell-derived cardiomyocytes: a versatile tool for arrhythmia research. Circ. Res. 112, 961–968. 10.1161/circresaha.112.268623 [DOI] [PubMed] [Google Scholar]
- Siu C. W., Lee Y.-K., Ho J. C.-Y., Lai W.-H., Chan Y.-C., Ng K.-M., et al. (2012). Modeling of lamin A/C mutation premature cardiac aging using patient-specific induced pluripotent stem cells. Aging 4, 803–822. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Snir M., Kehat I., Gepstein A., Coleman R., Itskovitz-Eldor J., Livne E., et al. (2003). Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 285, H2355–H2363. 10.1152/ajpheart.00020.2003 [DOI] [PubMed] [Google Scholar]
- Takahashi H., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872. 10.1016/j.cell.2007.11.019 [DOI] [PubMed] [Google Scholar]
- Thavandiran N., Dubois N. C., Mikryukov A., Masse S., Beca B., Simmons C., et al. (2013). Design and formulation of functional pluripotent stem cell-derived cardiac microtissues. Proc. Natl. Acad. Sci. U.S.A. 49, E4698–E4707. 10.1073/pnas.1311120110 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thurley K., Tovey S. C., Moenke G., Prince V. L., Meena A., Thomas A. P., et al. (2014). Reliable encoding of stimulus intensities within random sequences of intracellular Ca2+ spikes. Sci. Signal. 7:ra59. 10.1126/scisignal.2005237 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tian Y., Morrisey E. E. (2012). Importance of myocyte-nonmyocyte interactions in cardiac development and disease. Circ. Res. 110, 1023–1034. 10.1161/circresaha.111.243899 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tulloch N. L., Muskheli V., Razumova M. V., Korte F. S., Regnier M., Hauch K. D., et al. (2011). Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ. Res. 109, 47–59. 10.1161/circresaha.110.237206 [DOI] [PMC free article] [PubMed] [Google Scholar]
- van den Berg C. W., Elliot D. A., Braam S. R., Mummery C. L., Davis R. P. (2016). Differentiation of human pluripotent stem cells to cardiomyocytes under defined conditions. Methods Mol. Biol. 1353, 163–180. 10.1007/7651_2014_178 [DOI] [PubMed] [Google Scholar]
- Wang H., Hao J., Hong C. C. (2011). Cardiac induction of embryonic stem cells by a small molecule inhibitor of Wnt/B-catenin signaling. ACS Chem. Biol. 6, 192–197. 10.1021/cb100323z [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weisbrod D., Peretz A., Ziskind A., Menaker N., Oz S., Barad L., et al. (2013). SK4 Ca2+ activated K+ channel is a critical player in cardiac pacemaker derived from human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 110, e1685–e1694. 10.1073/pnas.1221022110 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yang X., Pabon L., Murry C. E. (2014). Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ. Res. 114, 511–523. 10.1161/circresaha.114.300558 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yazawa M., Hseuh B., Jia X., Pasca A. M., Bernstein J. A., Hallmayer J., et al. (2011). Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy Syndrome. Nature 471, 230–234. 10.1038/nature09855 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yokoo N., Baba S., Kaichi S., Niwa A., Mima A., Mima T., et al. (2009). The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. Biochem. Biophys. Res. Commun. 387, 482–488. 10.1016/j.bbrc.2009.07.052 [DOI] [PubMed] [Google Scholar]
- Yu J., Vodyanik M. A., Smuga-Otoo K., Antosiewicz-Bourget J., Frane J. L., Tian S., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920. 10.1126/science.1151526 [DOI] [PubMed] [Google Scholar]
- Zhang J., Wilson G. F., Soerens A. G., Koonce C. H., Yu J., Palecek S. P., et al. (2009). Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res 104, e30–e41. 10.1161/circresaha.108.192237 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang P., Su J., Mende U. (2012). Cross talk between cardiac myocytes and fibroblasts: from multiscale investigative approaches to mechanisms and functional consequences. Am. J. Physiol. Heart Circ. Physiol. 303, H1385–H1396. 10.1152/ajpheart.01167.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zwi L., Caspi O., Arbel G., Huber I., Gepstein A., Park I. H., et al. (2009). Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120, 1513–1523. 10.1161/CIRCULATIONAHA.109.868885 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.